
Keywords: pulmonary drug delivery; powder technology; formulation vehicle; milling; HPLC; IPF; idiopathic pulmonary fibrosis; SPI; salvianolic acids and tanshinones dry powder for inhalation; STW; salvianolic acids and tanshinones composite powder; DPI; dry powder